Advertisement

Topics

Latest Biotechnology, Pharmaceutical and Healthcare News from Seeking Alpha

16:11 EDT 18th August 2018 | BioPortfolio

Here are the most relevant search results for "Seeking Alpha" found in our extensive news archives from over 250 global news sources.

More Information about Seeking Alpha on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Seeking Alpha for you to read. Along with our medical data and news we also list Seeking Alpha Clinical Trials, which are updated daily. BioPortfolio also has a large database of Seeking Alpha Companies for you to search.

Showing News Articles 1–25 of 6,100+ from Seeking Alpha

Saturday 18th August 2018

Why Adaptimmune's Forward Momentum May Be The Perfect Entry Point

TG Therapeutics Is Worth A Look Before Phase 3 Combination Cancer Data

Friday 17th August 2018

Still Not Much Momentum At Accuray

Trump Insurance For Johnson & Johnson

More Volatility Ahead For Arbutus Biopharma

Cigna: Pyrrhic Victory?

Mallinckrodt Is An Attractive Buy Opportunity In 2018

Loxo Oncology: Out Of The Frying Pan And Into The Fire (Part 2/2)

Catalyst-Rich Months Ahead For The Alkermes Pipeline

Humana Inc. 2018 Q2 - Results - Earnings Call Slides

Medicure Inc. 2018 Q2 - Results - Earnings Call Slides

Acrux Ltd. 2018 Q4 - Results - Earnings Call Slides

Edwards Lifesciences: Good For The Heart And Your Portfolio

Amniofix Injectable Reimbursement: The Sky Is Falling

Exact Sciences: Overreaction Achievement Unlocked

Zafgen: This Revaluation And Catalyst Story Is Still In Early Innings

Sorrento Therapeutics's Pain Management Is Undervalued; Just Take A Look

AbbVie: Remarkable 700% Return Potential Over Next Decade (Dividend Sensei)

AbbVie: Remarkable Return Potential Over Next Decade (Dividend Sensei)

Betting On Eiger's Foray Into Hepatitis D Therapeutics With Lonafarnib

Taking Another Look At AxoGen After A Nasty Post-Earnings Tumble

Ironwood Pharmaceuticals' Proposed Separation Should Offer A Favorable Outcome For Shareholders

Thursday 16th August 2018

Navidea Biopharmaceuticals' (NAVB) Interim CEO Jed Latkin on Q2 2018 Results - Earnings Call Transcript

Accuray, Inc. (ARAY) CEO Joshua Levine on Q4 2018 Results - Earnings Call Transcript

Axsome Therapeutics: Catalysts On The Horizon


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks